Related Experiment Video

Updated: Apr 18, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

21.2K

Diffuse pleural thickening following heart failure-related pleural effusions in an asbestos exposed patient

Matthew Evison, Philip Barber

    International Journal of Occupational and Environmental Health
    |January 14, 2015
    PubMed

    Keywords:
    Asbestos,Asbestos-related pleural disease,Benign asbestos-related pleural effusionDiffuse pleural thickening,

    More Related Videos

    Refined Murine Model of Idiopathic Pulmonary Fibrosis07:51

    Refined Murine Model of Idiopathic Pulmonary Fibrosis

    Published on: June 17, 2025

    1.4K
    Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice07:54

    Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

    Published on: December 21, 2019

    7.4K

    Related Concept Videos

    Pleural Effusion I: Introduction01:25

    Pleural Effusion I: Introduction

    Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
    There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
    6.0K
    Pleural Effusion II: Symptoms and Management01:28

    Pleural Effusion II: Symptoms and Management

    Pleural Effusion Overview
    A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
    Clinical Manifestations:
    1.2K
    Pleural Disorders: Types and Brief Description01:30

    Pleural Disorders: Types and Brief Description

    The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
    1.0K
    Chronic Obstructive Pulmonary Disease II: Emphysema01:23

    Chronic Obstructive Pulmonary Disease II: Emphysema

    Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
    2
    Pleura of the Lungs01:13

    Pleura of the Lungs

    The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
    11.3K
    Pneumothorax-II01:27

    Pneumothorax-II

    Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
    Clinical Manifestations:
    1.5K